Novartis sues three over generic Zometa

17-04-2013

Swiss pharmaceutical firm Novartis has filed a lawsuit against Accord Healthcare, Fresenius Kabi and Hikma Farmaceutica for applying to market generic versions of its cancer drug Zometa.


Novartis, Accord, Hikma Farmaceutica, Fresenius Kabi, generic Zometa

LSIPR